To further demonstrate that LAIR‐1 was related to PI3K‐AKT‐mTOR pathway regulation in HCC, we treated the LAIR‐1 siRNA group with the PI3K inhibitor LY294002. This evidence concerns the gene AKT1 and hepatocellular carcinoma.